ARCHIVES

How Much Is Life Worth? The $440 Billion Question

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

In Brief: St. Jude, Yale to Get Bristol-Myers Grants; Five Named for New Young Scientists Awards

May 6, 1988

“Proof Of Concept” Shown In Early Trial Of PKC-412

December 27, 2002

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

In Brief: Forget Hew – It’s No HHS; Cancer Control Advisory Committee Meeting Set For Oct. 22

October 5, 1979